●

Search

Insert text and press Enter to Search

Pharmacovigilance

Medical Information

About Us

Close

About Us Mission and Values Governance Ethics and Transparency Chiesi In The World Our History Chiesi Foundation

Ethics and Transparency Report Efpia Countries Switzerland Disclosure Transfer Value Patient Organization Support
Solutions

Close

Solutions Action Areas Products Transparency

Action Areas Air Care Rare
Sustainability

Close

Sustainability Our Approach Sustainability Report Governance Patients Environment Community Global Value Chain

Patients Patient Centric Approach Health Equity
Innovation

Close

Innovation Research And Development Pipeline Biotech Manufacturing Digital Health

Research And Development Clinical Trial Transparency and Data Sharing
Working At Chiesi

Close

Working At Chiesi Our Team Careers

Our Team Values, Culture And Leadership Organization of the Future Employee Experience
Partnering

Close

Partnering What We are Looking for Global Value Chain and Suppliers Chiesi Ventures
Media Hub

Close

Media Hub News Press Releases
it
Contacts

Careers

Pharmacovigilance

Medical Information

Governance

Mike Gordon

Executive Vice President Group General Counsel

Media Hub

VAT 01513360345

Company's Capital: Euro 75.000.000

Companies Register Office Parma N.15739

REA: 159271

© CHIESI Farmaceutici S.p.A.

Pharmacovilance

Speakup&BeHeard

Website Terms of Use

Social Media Terms of Use

PHARMACOVIGILANCE

To Report adverse drug events/reaction
please click here

Follow Us On

Certification Notice